Associations Between Alcohol Use and Liver-Related Outcomes in a Large National Cohort of Patients With Cirrhosis

被引:28
|
作者
Pearson, Meredith M. [1 ]
Kim, Nicole J. [1 ]
Berry, Kristin [2 ]
Moon, Andrew M. [3 ]
Su, Feng [1 ]
Vutien, Philip [1 ]
Green, Pamela K. [2 ]
Williams, Emily C. [2 ,4 ]
Ioannou, George N. [1 ,5 ]
机构
[1] Univ Washington, Div Gastroenterol & Hepatol, Seattle, WA 98195 USA
[2] Vet Affairs Puget Sound Hlth Care Syst, Hlth Serv Res & Dev, Seattle, WA USA
[3] Univ N Carolina, Div Gastroenterol & Hepatol, Chapel Hill, NC 27515 USA
[4] Univ Washington, Dept Hlth Serv, Seattle, WA 98195 USA
[5] Vet Affairs Puget Sound Hlth Care Syst, Div Gastroenterol, Seattle, WA USA
基金
美国国家卫生研究院;
关键词
CHRONIC HEPATITIS-C; HEPATOCELLULAR-CARCINOMA; RISK-FACTORS; VIRUS-INFECTION; USE DISORDER; CONSUMPTION; PROGRESSION; PREDICTION; MORTALITY; DISEASE;
D O I
10.1002/hep4.1776
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Alcohol use can cause hepatic necroinflammation and worsening portal hypertension in patients with cirrhosis. We aimed to evaluate the associations between degree of alcohol use and clinical liver-related outcomes according to etiology of cirrhosis. In this retrospective cohort analysis, 44,349 U.S. veterans with cirrhosis from alcohol-associated liver disease (ALD), chronic hepatitis C virus (HCV) infection, or nonalcoholic fatty liver disease were identified who completed the Alcohol Use Disorders Identification Test Consumption questionnaire in 2012. Based on this score, level of alcohol use was categorized as none, low level, or unhealthy. Multivariable Cox proportional hazards regression was used to assess for associations between alcohol use and mortality, cirrhosis decompensation (new ascites, encephalopathy, or variceal bleeding), and hepatocellular carcinoma (HCC). At baseline, 36.4% of patients endorsed alcohol use and 17.1% had unhealthy alcohol use. During a mean 4.9 years of follow-up, 25,806 (57.9%) patients died, 9,409 (21.4%) developed a new decompensation, and 4,733 (11.1%) developed HCC. In patients with ALD-cirrhosis and HCV-cirrhosis, unhealthy alcohol use, compared with no alcohol use, was associated with higher risks of mortality (adjusted hazard ratio [aHR] = 1.13, 95% confidence interval [CI] = 1.07-1.19 and aHR = 1.14, 95% CI = 1.08-1.20, respectively) and decompensation (aHR = 1.18, 95% CI = 1.07-1.30 and aHR = 1.08, 95% CI = 1.00-1.16, respectively). Alcohol use was not associated with HCC, regardless of cirrhosis etiology. Conclusion: Unhealthy alcohol use was common in patients with cirrhosis and was associated with higher risks of mortality and cirrhosis decompensation in patients with HCV-cirrhosis and ALD-cirrhosis. Therefore, health care providers should make every effort to help patients achieve abstinence. The lack of association between alcohol use and HCC merits further investigation.
引用
收藏
页码:2080 / 2095
页数:16
相关论文
共 50 条
  • [41] Statin use and liver-related prognosis among patients with MASLD
    Yun, Byungyoon
    Park, Heejoo
    Lee, Jian
    Kim, Beom Kyung
    Yoon, Jin-Ha
    JHEP REPORTS, 2025, 7 (04)
  • [42] SUB-CLASSIFICATION OF CIRRHOSIS AND PREDICTION OF LIVER-RELATED EVENTS USING FIBROSCAN IN PATIENTS WITH HBV-RELATED CIRRHOSIS
    Kim, S. U.
    Oh, H. J.
    Park, Y. N.
    Park, J. Y.
    Kim, D. Y.
    Ahn, S. H.
    Chon, C. Y.
    Han, K. -H.
    JOURNAL OF HEPATOLOGY, 2012, 56 : S34 - S34
  • [43] LIVER-RELATED OUTCOMES IN PATIENTS WITH HCV COMPENSATED LIVER CIRRHOSIS AFTER SVR: RESULTS FROM 5 YEARS OF FOLLOW-UP
    Morisco, F.
    Federico, A.
    Marignani, M.
    Lombardo, F. L.
    Cossiga, V.
    De Conte, A.
    Romeo, M.
    Cipullo, M.
    Begini, P.
    Gioli, F.
    Stroffolini, T.
    DIGESTIVE AND LIVER DISEASE, 2024, 56 : S202 - S202
  • [44] Use of statins among patients with cirrhosis due to alcohol-related liver disease-a danish nationwide cohort study
    Ramsing, Anna Marine Solling
    Kraglund, Frederik
    Jepsen, Peter
    JOURNAL OF HEPATOLOGY, 2022, 77 : S123 - S124
  • [45] Transplant-related trauma, personal growth and alcohol use outcomes in a cohort of patients receiving transplants for alcohol associated liver disease
    Kruckenberg, Katherine M.
    Shenai, Neeta
    Dew, Mary Amanda
    Switzer, Galen
    Hughes, Christopher
    DiMartini, Andrea F.
    GENERAL HOSPITAL PSYCHIATRY, 2021, 72 : 73 - 80
  • [46] Metabolomics as a tool to predict the risk of decompensation or liver-related death in patients with compensated cirrhosis
    Nicoara-Farcau, Oana J.
    Lozano, Juan J.
    Alonso, Cristina
    Sidorova, Julia
    Villanueva, Candid
    Albillos, Augustin
    Genesca, Joan
    Llop, Elba
    Calleja, Jose L.
    Aracil, Carles
    Banares, Rafael
    Morillas, Rosa
    Poca, Maria
    Penas, Beatriz
    Augustin, Salvador
    Tantau, Marcel
    Thompson, Marcos
    Perez-Campuzano, Valeria
    Baiges, Anna
    Turon, Fanny
    Hernandez-Gea, Virginia G.
    Abraldes, Juan G.
    Tapias, Edilmar A.
    Torres, Ferran
    Bosch, Jaime
    Garcia-Pagan, Juan
    HEPATOLOGY, 2023, 77 (06) : 2052 - 2062
  • [47] COMPARING RATES OF DECOMPENSATION, HEPATOCELLULAR CARCINOMA, OVERALL AND LIVER-RELATED DEATH BETWEEN MASLD, METALD AND ALD IN A NATIONAL COHORT
    John, Binu
    Bastaich, Dustin
    Dahman, Bassam
    HEPATOLOGY, 2024, 80 : S841 - S842
  • [48] CHARACTERISTICS AND OUTCOMES OF TRANSGENDER PATIENTS WITH CIRRHOSIS: A NATIONAL COHORT STUDY
    Elhence, Hirsh
    Terrault, Norah
    Kahn, Jeffrey A.
    Lee, Brian P.
    HEPATOLOGY, 2023, 78 : S187 - S188
  • [49] Derivation and validation of the NAFLD cirrhosis score (NCS) to distinguish bridging fibrosis from cirrhosis and to predict liver-related outcomes
    Labenz, Christian
    Toenges, Gerrit
    Galle, Peter
    Zheng, Ming-Hua
    Ding, Dora
    Myers, Robert
    Armandi, Angelo
    Ampuero, Javier
    Romero Gomez, Manuel
    Bugianesi, Elisabetta
    Schattenberg, Joern M.
    JOURNAL OF HEPATOLOGY, 2021, 75 : S556 - S557
  • [50] ALT levels, alcohol use, and metabolic risk factors have prognostic relevance for liver-related outcomes in the general population
    Mannisto, Ville
    Salomaa, Veikko
    Jula, Antti
    Lundqvist, Annamari
    Mannisto, Satu
    Perola, Markus
    Aberg, Fredrik
    JHEP REPORTS, 2024, 6 (10)